Literature DB >> 11172401

Domino split-liver transplantation from a living donor: case reports of in situ and ex situ splitting.

Y Inomata1, T Nakamura, S Uemoto, K Tanaka, G Wakabayashi, M Shimazu.   

Abstract

The liver from a patient with familial amyloid polyneuropathy (FAP) scheduled for living donor liver transplantation can be split and transplanted into 2 adult patients with end-stage liver disease. We have performed this procedure, called domino split transplantation, twice. The native liver was split in situ in 1 patient with FAP and ex situ in the other patient with FAP. The recipients of the livers from the patients with FAP and their living donors are doing well without serious complications. Of the 4 secondary recipients, 3 patients survived. Domino split-liver transplantation from a living donor thus appears to be a promising procedure for expansion of the donor pool.

Entities:  

Mesh:

Year:  2001        PMID: 11172401     DOI: 10.1053/jlts.2001.21299

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  3 in total

1.  Outcomes of adult-to-adult living donor liver transplantation: a single institution's experience with 335 consecutive cases.

Authors:  Daisuke Morioka; Hiroto Egawa; Mureo Kasahara; Takashi Ito; Hironori Haga; Yasutsugu Takada; Hiroshi Shimada; Koichi Tanaka
Journal:  Ann Surg       Date:  2007-02       Impact factor: 12.969

2.  Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation: a single center experience.

Authors:  Hiroto Egawa; Kaoru Taira; Satoshi Teramukai; Hironori Haga; Yoshihide Ueda; Atsushi Yonezawa; Satohiro Masuda; Hiroaki Tsuji; Eishi Ashihara; Yasutsugu Takada; Shinji Uemoto
Journal:  Dig Dis Sci       Date:  2009-03-07       Impact factor: 3.199

3.  Domino-liver transplantation: toward a safer and simpler technique in both donor and recipient.

Authors:  Jan Lerut; Maxime Foguenne; Quirino Lai; Jean de Ville de Goyet
Journal:  Updates Surg       Date:  2020-09-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.